Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: Results of a prospective study

Clinical Interventions in Aging

Volumn 11, Issue , 2016, Pages 571-578

  Gatell Tortajada, Jordi ^a  

^a Institut Català de Retina   (Spain)

Author keywords

Artificial tears; Dry eye symptoms; Eye discomfort; Nutraceutical supplement; Ocular inflammation; Omega 3 polyunsaturated fatty acids

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARTIFICIAL TEAR; ASCORBIC ACID; COPPER; CYSTEINE; EYE DROPS; GLUTATHIONE; MAGNESIUM; MINERAL; NUTRACEUTICAL; OMEGA 3 FATTY ACID; RETINOL; SELENIUM; TYROSINE; VITAMIN; ZINC;

ADULT; ARTICLE; BLURRED VISION; CLINICAL ASSESSMENT; CONJUNCTIVAL HYPEREMIA; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRY EYE; EYE DISCOMFORT; EYE PAIN; EYE REDNESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHYSICAL TOLERANCE; PROSPECTIVE STUDY; SCHIRMER TEST; TEAR BREAKUP TIME; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL SYSTEM PARAMETERS; AGED; CLINICAL TRIAL; DIETARY SUPPLEMENT; DRY EYE SYNDROMES; LACRIMAL FLUID; MIDDLE AGED; ORAL DRUG ADMINISTRATION; SPAIN;

ADMINISTRATION, ORAL; ADULT; AGED; ANTIOXIDANTS; DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; MINERALS; PROSPECTIVE STUDIES; SPAIN; TEARS; TREATMENT OUTCOME; VITAMINS;

EID: 84969913435     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S98102     Document Type: Article

References (29)

1. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318-326.
2. Pflugfelder SC. Prevalence, burden, and pharmacoeconomics of dry eye disease. Am J Manag Care. 2008;14(3 Suppl):S102-S106.
3. Yazdani C, McLaughlin T, Smeeding JE, Walt J. Prevalence of treated dry eye disease in a managed care population. Clin Ther. 2001;23(10):1672-1682.
4. Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30(4):379-387.
5. Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R; Impact of Dry Eye on Everyday Life (IDEEL) Study Group. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011;9:111.
6. Kaštelan S, Tomić M, Salopek-Rabatić J, Novak B. Diagnostic procedures and management of dry eye. BioMed Res Int. 2013;2013:309723.
7. Wei Y, Asbell PA. The core mechanism of dry eye disease in inflammation. Eye Cont Lens. 2014;40(4):248-256.
8. Bahvsar AS, Bahvsar SG, Jain SM. A review on recent advances in dry eye: Pathogenesis and management. Oman J Ophthalmol. 2011;4(2):50-56.
9. Rosenberg ES, Asbell PA. Essential fatty acids in the treatment of dry eye. Ocul Surf. 2010;8(1):18-28.
10. Roncone M, Bartlett H, Eperjesi F. Essential fatty acids for dry eye: a review. Cont Lens Anterior Eye. 2010;33(2):49-54.
11. Oleñik A, Jiménez-Alfaro I, Alejandre-Alba N, Mahillo-Fernández I. A randomised, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging. 2013;8:1133-1138.
12. Pinazo-Durán MD, Galbis-Estrada C, Pons-Vázquez S, Cantú-Dibildox J, Marco-Ramírez C, Benítez-del-Castillo J. Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging. 2013;8:139-148.
13. Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Cont Lens Anterior Eye. 2008;31(13):141-146.
14. Oleñik A. Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study. Clin Ophthalmol. 2014;8:169-176.
15. Bhargava R, Kumar P, Phogat H, Kaur A, Kumar M. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Cont Lens Anterior Eye. 2015;38(3):206-210.
16. Brignole-Baudouin F, Baudouin C, Aragona P, et al. A multicentre, double-masked, randomized, controlled trial assessing the effect of oral supplementation of omega-3 and omega-6 fatty acids on a conjunctival inflammatory marker in dry eye patients. Acta Ophthalmol. 2011;89(7):e591-e597.
17. Liu A, Ji J. Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit. 2014;20:1583-1589.
18. Zhu W, Wu Y, Li G, Wang J, Li X. Efficacy of polyunsaturated fatty acids for dry eye syndrome: a meta-analysis of randomized controlled trials. Nutr Rev. 2014;72(10):662-671.
19. Bron A, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7): 640-650.
20. Official Journal of the European Union. Commission Regulation (EU) No 432/2012 of 16 May 2012. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32012R0432&qid=1452674156190&from=EN. Accessed December 10, 2013.
21. Bogdanov P, Domingo JC. Docosahexaenoic acid improves endogen antioxidant defense in ARPE-19 cells. Poster presented at: ARVO Congress, May 1, 2008. Poster 5932/A306.
22. Domingo P, Joan C, Villegas G, Jose A, inventor; Brudy Technology, S.L., assignee. Use of DHA for treating pathology associated with cellular oxidative damage. patent EP1962825. 2015 Jul 31.
23. Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Deutsches Ärzteblatt Int. 2015;112(5):71-81.
24. Drouault-Holowacz S, Bieuvelet S, Rigal D, et al. Antioxidants intake and dry eye syndrome: a crossover, placebo-controlled, randomized trial. Eur J Ophthalmol. 2009;19(3):337-342.
25. Cortina MS, Bazan HE. Docosahexaenoic acid, protectins and dry eye. Curr Opin Clin Nutr Metab Care. 2011;14(2):132-137.
26. Miljanović B, Trivedi KA, Dana MR, Gilbard JP, Buring JE, Schaumberg DA. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr. 2005;82(4):887-893.
27. Downie LE, Keller PR, Vingrys AJ. An evidence-based analysis of Australian optometrists’ dry eye practices. Optom Vis Sci. 2013;90(12):1385-1395.
28. Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjögren disease. Ocul Surf. 2015;13(2):118-132.
29. University of Pennsylvania. Dry Assessment and Management Study (DREAM). Available from: https://clinicaltrials.gov/ct2/show/NCT02128763?term=dream%26rank=5. NLM identifier:NCT02128763. Accessed November 17, 2015.